Physician profile
Frank Macri
NPI 1093708828
$508.42
in general payments reported to CMS, 2019-2025
12 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.22 · 2021: $82.95 · 2022: $36.69 · 2023: $40.60 · 2024: $118 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $121.59 | 2023-2025 | Stravix Pl, Grafix Pl, Oasis |
| Novo Nordisk INC | $82.95 | 2021 | |
| Janssen Pharmaceuticals, INC | $68.22 | 2019 | |
| Paratek Pharmaceuticals, INC. | $60.03 | 2024-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $41.91 | 2024 | |
| Averitas Pharma INC. | $25.62 | 2025 | Qutenza |
| Orthofix Medical, INC. | $23.34 | 2025 | Physio-Stim |
| Nevro Corp. | $22.12 | 2022 | |
| Ebi, LLC | $17.19 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $17.19 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Integra Lifesciences Corporation | $14.57 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Macri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.